ATE491026T1 - Ply-gbs-lysinmutanten - Google Patents

Ply-gbs-lysinmutanten

Info

Publication number
ATE491026T1
ATE491026T1 AT06813511T AT06813511T ATE491026T1 AT E491026 T1 ATE491026 T1 AT E491026T1 AT 06813511 T AT06813511 T AT 06813511T AT 06813511 T AT06813511 T AT 06813511T AT E491026 T1 ATE491026 T1 AT E491026T1
Authority
AT
Austria
Prior art keywords
gbs
plygbs
streptococci
lysins
bacteria
Prior art date
Application number
AT06813511T
Other languages
English (en)
Inventor
Vincent Fischetti
Qi Cheng
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Application granted granted Critical
Publication of ATE491026T1 publication Critical patent/ATE491026T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06813511T 2005-08-24 2006-08-17 Ply-gbs-lysinmutanten ATE491026T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71093605P 2005-08-24 2005-08-24
PCT/US2006/032176 WO2007024628A2 (en) 2005-08-24 2006-08-17 Ply-gbs mutant lysins

Publications (1)

Publication Number Publication Date
ATE491026T1 true ATE491026T1 (de) 2010-12-15

Family

ID=37772174

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06813511T ATE491026T1 (de) 2005-08-24 2006-08-17 Ply-gbs-lysinmutanten

Country Status (9)

Country Link
US (1) US8105585B2 (de)
EP (2) EP2360248A1 (de)
JP (1) JP2009506033A (de)
CN (1) CN101297034A (de)
AT (1) ATE491026T1 (de)
CA (1) CA2620903A1 (de)
DE (1) DE602006018746D1 (de)
ES (1) ES2357626T3 (de)
WO (1) WO2007024628A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008018854A2 (en) * 2005-06-06 2008-02-14 The Rockefeller University Bactiophage lysins for bacillus anthracis
CN101297034A (zh) 2005-08-24 2008-10-29 洛克菲勒大学 Ply-gbs突变溶素
WO2010002959A2 (en) * 2008-07-03 2010-01-07 The Rockefeller University A chimeric bacteriophage lysin with activity against staphylococci bacteria
MX383544B (es) 2011-04-21 2025-03-14 Univ Rockefeller Lisinas de bacteriofago de streptococcus para la deteccion y tratamiento de bacterias gram positivas
CA2851270C (en) 2011-10-05 2023-03-14 The Rockefeller University Dimeric bacteriophage lysins
CN102516398B (zh) * 2011-12-27 2014-07-16 中国科学院遗传与发育生物学研究所 抗乳房炎转基因小鼠模型的构建方法及其专用载体
RU2646102C2 (ru) 2012-05-09 2018-03-01 Контрафект Корпорейшн Предотвращение, разрушение и обработка биопленки лизином бактериофага
AU2013259512B2 (en) 2012-05-09 2018-01-25 Contrafect Corporation Bacteriophage lysin and antibiotic combinations against gram positive bacteria
DE102013106455A1 (de) 2013-06-20 2014-12-24 Airbus Defence and Space GmbH Verfahren zur Dekontamination von bakteriologischen Verunreinigungen
CN109152822B (zh) 2016-05-12 2023-12-05 抗非特公司 用于评估和确定抗菌多肽的最小抑制浓度的肉汤微量稀释法
CN107083434B (zh) * 2017-06-05 2020-09-08 武汉赛思锐微生物技术有限公司 一种非诊断目的的荧光pcr定量检测b族链球菌的样本前处理方法
EA202090748A1 (ru) * 2017-06-16 2020-08-11 Борис Славинович ФАРБЕР Биологически активные комбинаторные производные полисахаридов
EP3771463A1 (de) * 2019-07-29 2021-02-03 Ludwig-Maximilians-Universität München Stabilisierung therapeutischer proteine mit piperazin- oder morpholinhaltigen zwitterionischen puffersubstanzen
CN112501189A (zh) * 2020-12-30 2021-03-16 吉林大学 一种能杀死马链球菌马亚种的裂解酶及其医用用途
KR102713606B1 (ko) * 2022-07-26 2024-10-10 주식회사 인트론바이오테크놀로지 젖소유방염 치료용 항균단백질 조성물
KR102742550B1 (ko) * 2022-07-26 2024-12-18 주식회사 인트론바이오테크놀로지 연쇄상구균에 대하여 용균 활성을 갖는 항균단백질

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
JPH0830004B2 (ja) 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
DE3587814T2 (de) * 1985-03-30 1994-11-10 Marc Ballivet Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
EP0206448B1 (de) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hämoglobin, das an ein Poly(alkenylenoxid) gebunden ist
US4680338A (en) * 1985-10-17 1987-07-14 Immunomedics, Inc. Bifunctional linker
JPS63502716A (ja) 1986-03-07 1988-10-13 マサチューセッツ・インステチュート・オブ・テクノロジー 糖タンパク安定性の強化方法
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4948580A (en) 1988-12-08 1990-08-14 E. R. Squibb & Sons, Inc. Muco-bioadhesive composition
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
JPH02258718A (ja) 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5264563A (en) * 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
JPH08503950A (ja) 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5554380A (en) 1994-08-04 1996-09-10 Kv Pharmaceutical Company Bioadhesive pharmaceutical delivery system
EP1002529A1 (de) 1994-09-09 2000-05-24 Takeda Chemical Industries, Ltd. Zubereitung mit verzögerter Freigabe eines Metallsalz eines Peptids
SK281571B6 (sk) 1995-06-07 2001-05-10 Alkermes Controlled Therapeutics, Inc. Prostriedok na trvalé uvoľňovanie ľudského rastového hormónu
ZA965368B (en) 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US5942243A (en) * 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6056955A (en) * 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
EP1501925A4 (de) * 2002-05-17 2006-10-25 New Horizons Diagnostics Corp Identifizierung eines phagenassoziierten lytischen enzyms zum schnellen und spezifischen nachweisen und abtöten von bacillus anthracis
US20040081646A1 (en) * 2002-08-29 2004-04-29 Engler Jeffrey A. Group B Streptococcal phage lysin
US7569223B2 (en) * 2004-03-22 2009-08-04 The Rockefeller University Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions
US7638600B2 (en) * 2004-03-24 2009-12-29 The Rockefeller University Lytic enzymes and spore surface antigen for detection and treatment of Bacillus anthracis bacteria and spores
US7582291B2 (en) * 2005-06-30 2009-09-01 The Rockefeller University Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
CN101297034A (zh) 2005-08-24 2008-10-29 洛克菲勒大学 Ply-gbs突变溶素
WO2010002959A2 (en) 2008-07-03 2010-01-07 The Rockefeller University A chimeric bacteriophage lysin with activity against staphylococci bacteria

Also Published As

Publication number Publication date
DE602006018746D1 (de) 2011-01-20
CN101297034A (zh) 2008-10-29
ES2357626T3 (es) 2011-04-28
CA2620903A1 (en) 2007-03-01
EP1917355A2 (de) 2008-05-07
WO2007024628A3 (en) 2007-06-14
JP2009506033A (ja) 2009-02-12
EP2360248A1 (de) 2011-08-24
US8105585B2 (en) 2012-01-31
US20080221035A1 (en) 2008-09-11
EP1917355B1 (de) 2010-12-08
EP1917355A4 (de) 2009-05-27
WO2007024628A2 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
DE602006018746D1 (de) Ply-gbs-lysinmutanten
DE602005012276D1 (de) Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut
TW200507841A (en) Antibacterial agents
AU2003291227A1 (en) Antibacterial agents
TW200806317A (en) Methods for reducing protein aggregation
DE60215494D1 (de) Bicyclische, stickstoffhaltige heterocyclische derivate zur verwendung als antibakterielle mittel
UA93384C2 (ru) Способ получения стерилизированного порошкообразного панкреатина
DE60216614D1 (de) Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln
TW200716200A (en) Methods of reducing microbial contamination
TW200621256A (en) Formulations
WO2005072826A3 (en) Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection
EP1560821B8 (de) Antibakterielle wirkstoffe
NO20082425L (no) Formuleringer omfattende jorumycin-, reni-eramycin-, safracin- eller saframycin-relaterte forbindelser for behandling av proliferative sykdommer
WO2006081289A3 (en) Antibacterial agents
NO20072890L (no) Behandling av mastitt
WO2006081182A3 (en) Antibacterial agents
EA200400197A1 (ru) Способы получения поливалентных бактериофагов для лечения бактериальных инфекций
WO2007047608A3 (en) Fibrin targeted therapeutics
EP1781669A4 (de) Antibakterielle mittel
WO2006081178A3 (en) Antibacterial agents
IL194353A0 (en) Lysobactin amides
ATE433459T1 (de) Desoxo-nonadepsipeptide
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.
DE60041198D1 (de) Antimikrobielle zusammensetzungen
ATE455789T1 (de) Substituierte nonadepsipeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties